A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the world.
Obesity drugmaker lands first biopharma uplisting onto Nasdaq since last summer
For the first time since last summer, a biotech has uplisted from an over-the-counter stock exchange to the Nasdaq. Such a move has become a
April 13, 2024